Endophthalmitis following Intravitreal Injection, Cataract Surgery, and Vitrectomy: Clinical Features and Visual Outcomes

Purpose. To describe and compare the clinical features and visual outcomes of endophthalmitis following intravitreal injections (IVI), cataract surgery, and pars plana vitrectomy (PPV). Methods. This is a single-centre, retrospective study. All included patients had acute postoperative endophthalmit...

Full description

Saved in:
Bibliographic Details
Main Authors: Ana Maria Cunha, Maria Manuel Iglésias, Amândio Rocha-Sousa, Fernando Falcão-Reis, Manuel Falcão
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2021/9985821
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560632433475584
author Ana Maria Cunha
Maria Manuel Iglésias
Amândio Rocha-Sousa
Fernando Falcão-Reis
Manuel Falcão
author_facet Ana Maria Cunha
Maria Manuel Iglésias
Amândio Rocha-Sousa
Fernando Falcão-Reis
Manuel Falcão
author_sort Ana Maria Cunha
collection DOAJ
description Purpose. To describe and compare the clinical features and visual outcomes of endophthalmitis following intravitreal injections (IVI), cataract surgery, and pars plana vitrectomy (PPV). Methods. This is a single-centre, retrospective study. All included patients had acute postoperative endophthalmitis secondary to one of these three procedures. Visual acuity (VA), comorbidities, time to presentation, and treatment were assessed. The primary outcome was visual outcome. A poor outcome was considered if final VA was worse than or equal to counting fingers (CF) and a good outcome was classified as VA better than CF. Results. Over 12 years, a total of 61 patients were included. Twenty-seven cases were post-cataract endophthalmitis; twenty-five were post-IVI and nine post-PPV. Endophthalmitis post-PPV had a worse visual outcome (88.9% of patients with VA worse than or equal to CF 95% CI 51.3 to 100.0%) than endophthalmitis following cataract surgery (25.9% of patients with VA worse than or equal to CF 95% CI 11.0 to 39.9%) and the IVI subgroup (44.0% of VA worse than or equal to CF 95% CI 24.0 to 67.0%) (p=0.001 and p=0.047). There were no significant differences in the proportion of patients with a poor visual outcome between endophthalmitis following cataract surgery and IVI (p=0.171). Conclusions. The number of patients with poor visual outcomes following acute endophthalmitis was similar in endophthalmitis following IVI and cataract surgery, but better than endophthalmitis following vitrectomy.
format Article
id doaj-art-e0faf778705545679a0efbf5b9e34f4f
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-e0faf778705545679a0efbf5b9e34f4f2025-02-03T01:27:05ZengWileyJournal of Ophthalmology2090-004X2090-00582021-01-01202110.1155/2021/99858219985821Endophthalmitis following Intravitreal Injection, Cataract Surgery, and Vitrectomy: Clinical Features and Visual OutcomesAna Maria Cunha0Maria Manuel Iglésias1Amândio Rocha-Sousa2Fernando Falcão-Reis3Manuel Falcão4Department of Ophthalmology, Centro Hospitalar Universitário de São João, Porto, PortugalFaculty of Medicine, University of Porto, Porto, PortugalDepartment of Ophthalmology, Centro Hospitalar Universitário de São João, Porto, PortugalDepartment of Ophthalmology, Centro Hospitalar Universitário de São João, Porto, PortugalDepartment of Ophthalmology, Centro Hospitalar Universitário de São João, Porto, PortugalPurpose. To describe and compare the clinical features and visual outcomes of endophthalmitis following intravitreal injections (IVI), cataract surgery, and pars plana vitrectomy (PPV). Methods. This is a single-centre, retrospective study. All included patients had acute postoperative endophthalmitis secondary to one of these three procedures. Visual acuity (VA), comorbidities, time to presentation, and treatment were assessed. The primary outcome was visual outcome. A poor outcome was considered if final VA was worse than or equal to counting fingers (CF) and a good outcome was classified as VA better than CF. Results. Over 12 years, a total of 61 patients were included. Twenty-seven cases were post-cataract endophthalmitis; twenty-five were post-IVI and nine post-PPV. Endophthalmitis post-PPV had a worse visual outcome (88.9% of patients with VA worse than or equal to CF 95% CI 51.3 to 100.0%) than endophthalmitis following cataract surgery (25.9% of patients with VA worse than or equal to CF 95% CI 11.0 to 39.9%) and the IVI subgroup (44.0% of VA worse than or equal to CF 95% CI 24.0 to 67.0%) (p=0.001 and p=0.047). There were no significant differences in the proportion of patients with a poor visual outcome between endophthalmitis following cataract surgery and IVI (p=0.171). Conclusions. The number of patients with poor visual outcomes following acute endophthalmitis was similar in endophthalmitis following IVI and cataract surgery, but better than endophthalmitis following vitrectomy.http://dx.doi.org/10.1155/2021/9985821
spellingShingle Ana Maria Cunha
Maria Manuel Iglésias
Amândio Rocha-Sousa
Fernando Falcão-Reis
Manuel Falcão
Endophthalmitis following Intravitreal Injection, Cataract Surgery, and Vitrectomy: Clinical Features and Visual Outcomes
Journal of Ophthalmology
title Endophthalmitis following Intravitreal Injection, Cataract Surgery, and Vitrectomy: Clinical Features and Visual Outcomes
title_full Endophthalmitis following Intravitreal Injection, Cataract Surgery, and Vitrectomy: Clinical Features and Visual Outcomes
title_fullStr Endophthalmitis following Intravitreal Injection, Cataract Surgery, and Vitrectomy: Clinical Features and Visual Outcomes
title_full_unstemmed Endophthalmitis following Intravitreal Injection, Cataract Surgery, and Vitrectomy: Clinical Features and Visual Outcomes
title_short Endophthalmitis following Intravitreal Injection, Cataract Surgery, and Vitrectomy: Clinical Features and Visual Outcomes
title_sort endophthalmitis following intravitreal injection cataract surgery and vitrectomy clinical features and visual outcomes
url http://dx.doi.org/10.1155/2021/9985821
work_keys_str_mv AT anamariacunha endophthalmitisfollowingintravitrealinjectioncataractsurgeryandvitrectomyclinicalfeaturesandvisualoutcomes
AT mariamanueliglesias endophthalmitisfollowingintravitrealinjectioncataractsurgeryandvitrectomyclinicalfeaturesandvisualoutcomes
AT amandiorochasousa endophthalmitisfollowingintravitrealinjectioncataractsurgeryandvitrectomyclinicalfeaturesandvisualoutcomes
AT fernandofalcaoreis endophthalmitisfollowingintravitrealinjectioncataractsurgeryandvitrectomyclinicalfeaturesandvisualoutcomes
AT manuelfalcao endophthalmitisfollowingintravitrealinjectioncataractsurgeryandvitrectomyclinicalfeaturesandvisualoutcomes